Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

• Sophia Ceder,
• Sofi E. Eriksson,
• Ying Yu Liang,
• Emarndeena H. Cheteh,
• Si Min Zhang,
• Kenji M. Fujihara,
• Julie Bianchi,
• Vladimir J. N. Bykov,
• Lars Abrahmsen,
• Nicholas J. Clemons,
• Pär Nordlund,
• Sean G. Rudd,
• Klas G. Wiman

Affiliations

Sophia Ceder

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Sofi E. Eriksson

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Ying Yu Liang

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Emarndeena H. Cheteh

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Si Min Zhang

Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet

Kenji M. Fujihara

Cancer Research Division, Peter MacCallum Cancer Centre

Julie Bianchi

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Vladimir J. N. Bykov

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Lars Abrahmsen

Aprea Therapeutics AB

Nicholas J. Clemons

Cancer Research Division, Peter MacCallum Cancer Centre

Pär Nordlund

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6

Sean G. Rudd

Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet

Klas G. Wiman

Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6